wildpixel/iStock via Getty Images
- A memorandum of understanding brokered Monday between HHS and the Veterans Administration could bode well for companies developing psychedelic-based drug treatments.
- The MOU is intended to bolster “collaboration on the research, clinical development, and responsible deployment to veterans suffering from serious mental health
